Impact of peer support on virologic failure in HIV-infected patients on antiretroviral therapy - a cluster randomized controlled trial in Vietnam
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Impact of peer support on virologic failure in HIV-infected patients on antiretroviral therapy - a cluster randomized controlled trial in Vietnam ; volume:16 ; number:1 ; day:16 ; month:12 ; year:2016 ; pages:1-14 ; date:12.2016
BMC infectious diseases ; 16, Heft 1 (16.12.2016), 1-14, 12.2016
- Schlagwort
-
Allergie
Immunkrankheit
- Urheber
-
Cuong, Do Duy
- Beteiligte Personen und Organisationen
-
Sönnerborg, Anders
Van Tam, Vu
El-Khatib, Ziad
Santacatterina, Michele
Marrone, Gaetano
Nguyen, Thi Kim Chuc
Diwan, Vinod
Thorson, Anna
Le, Nicole K.
An, Pham Nhat
Larsson, Mattias
SpringerLink (Online service)
- DOI
-
10.1186/s12879-016-2017-x
- URN
-
urn:nbn:de:1111-201701167805
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Cuong, Do Duy
- Sönnerborg, Anders
- Van Tam, Vu
- El-Khatib, Ziad
- Santacatterina, Michele
- Marrone, Gaetano
- Nguyen, Thi Kim Chuc
- Diwan, Vinod
- Thorson, Anna
- Le, Nicole K.
- An, Pham Nhat
- Larsson, Mattias
- SpringerLink (Online service)
Ähnliche Objekte (12)
Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study
Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children
Decreased bone turnover in HIV-infected children on antiretroviral therapy
Improved virologic outcomes over time for HIV-infected patients on antiretroviral therapy in a cohort from Rio de Janeiro, 1997–2011
Platelet activity in HIV-infected patients on abacavir-containing antiretroviral therapy
Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda
Interruption of antiretroviral treatment in HIV-infected children
Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon
Durability of antiretroviral therapy and predictors of virologic failure among perinatally HIV-infected children in Tanzania: a four-year follow-up
Prevalence, rate, and predictors of virologic failure among adult HIV-Infected clients on second-line antiretroviral therapy (ART) in Tanzania (2018–2020): a retrospective cohort study
Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy
Impact of antiretroviral therapy on fertility desires among HIV-infected persons in rural Uganda
Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study
Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children
Decreased bone turnover in HIV-infected children on antiretroviral therapy
Improved virologic outcomes over time for HIV-infected patients on antiretroviral therapy in a cohort from Rio de Janeiro, 1997–2011
Platelet activity in HIV-infected patients on abacavir-containing antiretroviral therapy
Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda
Interruption of antiretroviral treatment in HIV-infected children
Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon
Durability of antiretroviral therapy and predictors of virologic failure among perinatally HIV-infected children in Tanzania: a four-year follow-up
Prevalence, rate, and predictors of virologic failure among adult HIV-Infected clients on second-line antiretroviral therapy (ART) in Tanzania (2018–2020): a retrospective cohort study
Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy
Impact of antiretroviral therapy on fertility desires among HIV-infected persons in rural Uganda
Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study
Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children
Decreased bone turnover in HIV-infected children on antiretroviral therapy
Improved virologic outcomes over time for HIV-infected patients on antiretroviral therapy in a cohort from Rio de Janeiro, 1997–2011
Platelet activity in HIV-infected patients on abacavir-containing antiretroviral therapy
Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda
Interruption of antiretroviral treatment in HIV-infected children
Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon
Durability of antiretroviral therapy and predictors of virologic failure among perinatally HIV-infected children in Tanzania: a four-year follow-up
Prevalence, rate, and predictors of virologic failure among adult HIV-Infected clients on second-line antiretroviral therapy (ART) in Tanzania (2018–2020): a retrospective cohort study
Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy